SAR, Cardiac Myocytes Protection Activity and 3D-QSAR Studies of Salubrinal and its Potent Derivatives

Author(s): J. Liu, K.-L. He, X. Li, R.-J. Li, C.-L. Liu, W. Zhong, S. Li

Journal Name: Current Medicinal Chemistry

Volume 19 , Issue 35 , 2012

Become EABM
Become Reviewer

Abstract:

Salubrinal is a selective inhibitor of endoplasmic reticulum (ER) stress and affords remarkable protection to cardiomyocytes. By studying the structure–activity relationship (SAR) of salubrinal, it was found that modification of the quinoline ring terminus and thiourea unit could confer the compound PP1-24 with markedly enhanced cardioprotective activity (EC50 ≤ 0.3 μM) that is 50-fold more potent than salubrinal. Comparative molecular field analysis (CoMFA) was performed using the obtained biological data and resulted in a statistically significant CoMFA model with high predictive power (q2 = 0.741, r2 = 0.991).

Keywords: Cardiomyocytes protection, UPR, endoplasmic reticulum (ER) stress, eukaryotic translation initiation factor 2 subunit α (eIF2α) phosphorylation, PP1/GADD34 complex inhibitor, salubrinal, structure–activity relationships (SAR), MTT, CoMFA model, predicted abilities.

Rights & PermissionsPrintExport Cite as

Article Details

VOLUME: 19
ISSUE: 35
Year: 2012
Page: [6072 - 6079]
Pages: 8
DOI: 10.2174/0929867311209066072
Price: $65

Article Metrics

PDF: 19